NUVB
NUVB
NYSE · Pharmaceuticals

Nuvation Bio Inc

$5.56
+0.23 (+4.32%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +677.3% upside
Low Target $30.63
Average Target $43.22
High Target $69.64
Current Price $5.56
Current
$5.56
Target
$43.22
$30.63 $43.22 avg $69.64
Scenario Analysis
Bear Case
$30.63
450.9%
Low target
Base Case
$43.22
+677.3%
Avg target
Bull Case
$69.64
+1,152.5%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$9.75
-43.0% from high
52-Week Low
$1.58
+251.9% from low
Target vs 52W High
$43.22
+343.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%